Erika Crawford

Erika Crawford serves as a primary procurement lead within the Food and Drug Administration, overseeing strategic acquisitions critical to advancing the agency’s mission of ensuring public health through scientific rigor and regulatory oversight. She manages a diverse portfolio of contracts focused on analytical laboratory instrumentation, digital diagnostic systems, and specialized IT services that support FDA’s scientific evaluation and compliance functions. Her work directly enables the agency’s modernization efforts in laboratory automation, data analytics, and real-time health product surveillance, ensuring that procurement decisions align with technical requirements and regulatory timelines. Crawford maintains robust relationships with leading federal contractors including Peraton Enterprise Solutions LLC, Deloitte Consulting LLP, Booz Allen Hamilton Inc., and MPF-ZAI Solutions LLC, partnering with firms that deliver advanced engineering, systems integration, and analytical software solutions. Her contracting approach emphasizes long-term vendor collaboration, particularly with firms possessing deep expertise in laboratory instrumentation, clinical data management, and compliance-driven software development. These partnerships are structured to support complex, high-stakes procurements requiring stringent validation and regulatory alignment. Her procurement patterns reflect a strong preference for open competition, with 64.1% of awards issued without set-aside designations, while maintaining a significant commitment to small business participation—35.9% of contracts are awarded under Total Small Business Set-Aside provisions. She consistently leverages FAR 19.5 to foster opportunities for qualified small businesses, ensuring broad vendor engagement without compromising technical rigor or mission-critical performance standards. Crawford’s primary NAICS focus lies in 334516 (Analytical Laboratory Instrument Manufacturing), reflecting her central role in procuring mass spectrometers, chromatography systems, and automated sample handling equipment. She also regularly acquires custom computer programming and systems design services under NAICS 541511 and 541512 to support data interoperability and regulatory decision-support platforms. Her domain expertise spans laboratory informatics, bioanalytical validation, and FDA-compliant software lifecycle management.